Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2016

Preventing germ cell death by inactivating aryl hydrocarbon
receptor (AHR)
P Esakky
Washington University School of Medicine in St. Louis

K H. Moley
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Esakky, P and Moley, K H., ,"Preventing germ cell death by inactivating aryl hydrocarbon receptor (AHR)."
Cell Death and Disease. 7,. e2116. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/4616

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

OPEN

Citation: Cell Death and Disease (2016) 7, e2116; doi:10.1038/cddis.2016.20
& 2016 Macmillan Publishers Limited All rights reserved 2041-4889/16

www.nature.com/cddis

NEWS AND COMMENTARY

Preventing germ cell death by inactivating aryl
hydrocarbon receptor (AHR)
P Esakky1,2 and KH Moley*,1,2
Cell Death and Disease (2016) 7, e2116; doi:10.1038/cddis.2016.20; published online 25 February 2016

Tobacco causes nearly six million deaths per year worldwide;
in the US, smoking and second-hand smoke exposure causes
one in every five deaths and incur almost $300 billion annually
in total economic costs.1 Approximately 35% of men of
reproductive age in the US smoke cigarettes, affecting not
only themselves but also the environment and their progeny.
Smoking causes infertility in men, and children born to male
smokers are at increased risk of childhood cancers and birth
defects, such as cardiac defects, cleft palate, renal agenesis,
and spina bifida. These effects are due to the accumulation of
toxic constituents of cigarette smoke (CS) in the systemic
circulation and seminal plasma.2 CS contains more than 7000
chemicals, including at least 539 polycyclic aromatic hydrocarbons (PAHs), of which 69 are proven carcinogens that are
also products of incomplete combustion of fossil fuels and
environmental pollution.3
PAHs such as dioxins, and benzopyrene in cigarette
smoke condensate (CSC) or tar, exert their cytotoxicity by
activating the ligand-inducible transcription factor, aryl hydrocarbon receptor (AHR).4 Whereas the endogenous activation
of AHR by growth factors and dietary metabolites like
kynurenic acid maintains tissue homeostasis and regulation
of normal immune function, its exogenous activation by PAHs
leads to spermatogenic arrest, suppression of meiosis, cell
cycle arrest, spermatocyte cell death, and male infertility.5,6
However, the precise role of AHR in spermatocyte susceptibility to CSC is still emerging. In an earlier study,7 we
demonstrated that the CSC induced several molecular
and phenotypic changes in the spermatocyte cell line, (GC2spd(ts)).8 By using a competitive AHR-specific pharmacological inhibitor, CH223191,9 we observed that many of the
gene expression changes were dependent on AHR signaling.
In the subsequent work, we showed that inhibition of AHR
abrogated cell cycle arrest in spermatocytes.10 However,
given that AHR is required for normal sperm development in
mice,11 our recent report published in Cell Death Discovery12
compared the effects of pharmacological inhibition of AHR to
knockdown of AHR expression, yielding intriguing findings
(Figure 1).
We first characterized the effects of CSC on GC-2spd(ts)
spermatocytes and found that CSC caused oxidative stress
both in the cytoplasm and the mitochondria, though it did not
affect mitochondrial membrane potential. Additionally, CSC

treatment of spermatocytes promoted apoptosis, as indicated
by increased expression of both anti- and pro-apoptotic genes,
DNA damage, activation of caspases 3 and 7, and
plasma membrane damage. Others have reported similar
results in different cell types.13 Pretreatment of the cells with
CH223191 significantly reduced several of these effects,
including DNA damage, caspase activation, and membrane
alteration.
To compare the effects of AHR inhibition to reduction of AHR
expression, we used siRNA to knockdown expression of Ahr
in spermatocytes by 70%. Strikingly, we observed that Ahr
knockdown did not abrogate many of the CSC-mediated
effects that were suppressed by AHR inhibition. For example,
Ahr knockdown did not reduce CSC-mediated caspase
activation or plasma membrane damage. Moreover, spermatocytes in which Ahr was knocked down had higher levels of
DNA damage than control spermatocytes. This finding
suggests a regulatory role for AHR in the early stages of
DNA damage or repair7 and supports an earlier finding
that loss of AHR triggers DNA damage.14 To confirm these
findings, we compared control and Ahr-null mouse embryonic
fibroblasts (MEFs) and found that complete loss of Ahr was
unable to prevent the CSC-mediated increase in caspase
activation and membrane damage.
We demonstrated earlier10 that the cross talk between
AHR–NRF2 pathway and MAPK signaling is required for CSCinduced spermatocyte cell death. However, here we found that
MAPK inhibitors could not prevent CSC-induced membrane
damage in spermatocytes. We interpret this finding to mean
that the membrane damage is directly caused by the CSCinduced increase in free oxygen radicals and the involvement
of other signaling mediators in addition to the MAPK pathway
as reported by others in rat lung.15 Our results reveal that
pharmacological inhibition and genetic manipulation of AHR
have different effects; this fact should be kept in mind in future
studies. More importantly, our data indicate that inhibition of
AHR by using drugs such as CH223191 may be a viable
prophylactic strategy to prevent germ cell death mediated by
exposure to CS and other environmental pollutants
containing PAHs.
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Figure 1 A schematic representation of proposed CSC-mediated cell death regulation through AHR in spermatocytes. Growth factors maintain tissue homeostasis through
AHR, which promotes expression of cyclins by forming growth-stimulating complex with molecules such as retinoblastoma (unexposed). On the other, CSC via PAHs mediates
cross talk between AHR and MAPKs. Inhibition of activated MAPKs abrogates cell cycle arrest but fails preventing membrane damage. Pretreatment with AHR-inh (CH223191)
attenuates CSC-induced DNA strand breaks, caspase activation, and membrane alteration (events marked in red). However, genetic silencing of Ahr either by siRNA knockdown
in spermatocytes or absence of Ahr in knockout MEF elevates ROS, enhances expression of pro- and anti-apoptotic proteins, and promotes apoptotic cascade upon exposure to
CSC (marked with blue arrow). Genetic manipulation and pharmacological inhibition distinguishes the protective role of AHR in maintaining normal cellular homeostasis and
advocates AHR as a potential prophylactic therapeutic target to promote cell survival and growth under CS-exposed environment, respectively. CSC-exposed is colored yellow on
right and findings of this study are italicized. MAPKs, mitogen-activated protein kinases; ROS, reactive oxygen species
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